Percutaneous closure of patent ductus arteriosus in adults using different devices. Rev Esp Cardiol. 2010;63:726 9. S4.1.5-3. Jeong Y-H, Yun T-J, Song J-M, et al. Left ventricular remodeling and change of systolic function after closure of patent ductus arteriosus in adults: device and surgical closure. Am Heart J. 2007;154:436 40. S4.1.5-4. Zabal C, Garc a-Montes JA, Buend a-Hern ndez A, et al. Percutaneous closure of hypertensive ductus arteriosus. Heart. 2010;96:625 9. S4.1.5-5. Kouchoukos NT, Blackstone EH, Kirklin JW. Surgical implications of pulmonary hypertension in congenital heart disease. Adv Cardiol. 1978:225 31. S4.1.5-6. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998 2005 J Pediatr. 2008;153:807 13. S4.1.5-7. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890 900. S4.1.5-8. Record RG, McKeown T. Observations relating to the aetiology of patent ductus arteriosus. Br Heart J. 1953;15:376 86. 4.2. Left-Sided Obstructive Lesions 4.2.1. Cor Triatriatum S4.2.1-1. Ozyuksel A, Yildirim O, Avsar M, et al. Surgical correction of cor triatriatum sinister in the paediatric population: mid-term results in 15 cases. Eur J Cardiothorac Surg. 2015;47:e25 8. S4.2.1-2. Yaroglu Kazanci S, Emani S, McElhinney DB. Outcome after repair of cor triatriatum. Am J Cardiol. 2012;109:412 6. S4.2.1-3. Saxena P, Burkhart HM, Schaff HV, et al. Surgical repair of cor tria- triatum sinister: the Mayo Clinic 50-year experience. Ann Thorac Surg. 2014;97:1659 63. S4.2.1-4. Alphonso N, N rgaard MA, Newcomb A, et al. Cor triatriatum: presentation, diagnosis and long-term surgical results. Ann Thorac Surg. 2005;80:1666 71. 4.2.2. Congenital Mitral Stenosis S4.2.2-1. Schaverien MV, Freedom RM, McCrindle BW. Independent factors associated with outcomes of parachute mitral valve in 84 patients. Circulation. 2004;109:2309 13. S4.2.2-2. Marino BS, Kruge LE, Cho CJ, et al. 